Intrathecal baclofen therapy in children with severe spasticity: Outcome and complications

Matthias Walter1, Stefan Altermatt, Claudia Furrer

  • 1Neuro-Urology, Spinal Cord Injury Centre & Research, University of Zurich, Balgrist University Hospital , Zurich , Switzerland .

Insights

Intrathecal baclofen (ITB) therapy effectively reduces lower limb spasticity in children with congenital brain injuries. However, close patient monitoring is crucial due to a high incidence of complications, particularly early after implantation.

Area of Science:

  • Pediatric Neurology
  • Neurosurgery
  • Rehabilitation Medicine

Background:

  • Severe spasticity in children with congenital brain injuries significantly impacts motor function and quality of life.
  • Intrathecal baclofen (ITB) therapy is a potential treatment option for refractory spasticity.

Purpose of the Study:

  • To evaluate the clinical effectiveness of ITB therapy in reducing spasticity in pediatric patients.
  • To determine the incidence and types of complications associated with ITB therapy in this population.

Main Methods:

  • Retrospective review of medical charts for 15 pediatric patients with congenital brain injuries.
  • Patients received ITB implantation for severe spasticity between 2003 and 2009.
  • Data analysis focused on changes in spasticity (Modified Ashworth Scale) and complication rates.

Main Results:

  • ITB therapy significantly decreased lower limb spasticity (p < 0.05) with increased baclofen dosage (p = 0.001).
  • A significant increase in Cobb angle was observed in patients with pre-existing scoliosis (p < 0.05).
  • Six patients (40%) experienced 10 complications (9 device-related, 1 accidental), primarily within three years post-implantation.

Conclusions:

  • Intrathecal baclofen is an effective treatment for reducing lower limb spasticity in pediatric patients.
  • The high rate of complications necessitates vigilant monitoring, especially during the early post-operative phase.
Abstract

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...